Cargando…
Protective Effect of Val(129)-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease
Bovine spongiform encephalopathy (BSE) is the only known zoonotic prion that causes variant Creutzfeldt-Jakob disease (vCJD) in humans. The major risk determinant for this disease is the polymorphic codon 129 of the human prion protein (Hu-PrP), where either methionine (Met(129)) or valine (Val(129)...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572891/ https://www.ncbi.nlm.nih.gov/pubmed/28820136 http://dx.doi.org/10.3201/eid2309.161948 |
_version_ | 1783259583393824768 |
---|---|
author | Fernández-Borges, Natalia Espinosa, Juan Carlos Marín-Moreno, Alba Aguilar-Calvo, Patricia Asante, Emmanuel A. Kitamoto, Tetsuyuki Mohri, Shirou Andréoletti, Olivier Torres, Juan María |
author_facet | Fernández-Borges, Natalia Espinosa, Juan Carlos Marín-Moreno, Alba Aguilar-Calvo, Patricia Asante, Emmanuel A. Kitamoto, Tetsuyuki Mohri, Shirou Andréoletti, Olivier Torres, Juan María |
author_sort | Fernández-Borges, Natalia |
collection | PubMed |
description | Bovine spongiform encephalopathy (BSE) is the only known zoonotic prion that causes variant Creutzfeldt-Jakob disease (vCJD) in humans. The major risk determinant for this disease is the polymorphic codon 129 of the human prion protein (Hu-PrP), where either methionine (Met(129)) or valine (Val(129)) can be encoded. To date, all clinical and neuropathologically confirmed vCJD cases have been Met(129) homozygous, with the exception of 1 recently reported Met/Val heterozygous case. Here, we found that transgenic mice homozygous for Val(129) Hu-PrP show severely restricted propagation of the BSE prion strain, but this constraint can be partially overcome by adaptation of the BSE agent to the Met(129) Hu-PrP. In addition, the transmission of vCJD to transgenic mice homozygous for Val(129) Hu-PrP resulted in a prion with distinct strain features. These observations may indicate increased risk for vCJD secondary transmission in Val(129) Hu-PrP–positive humans with the emergence of new strain features. |
format | Online Article Text |
id | pubmed-5572891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-55728912017-09-02 Protective Effect of Val(129)-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease Fernández-Borges, Natalia Espinosa, Juan Carlos Marín-Moreno, Alba Aguilar-Calvo, Patricia Asante, Emmanuel A. Kitamoto, Tetsuyuki Mohri, Shirou Andréoletti, Olivier Torres, Juan María Emerg Infect Dis Research Bovine spongiform encephalopathy (BSE) is the only known zoonotic prion that causes variant Creutzfeldt-Jakob disease (vCJD) in humans. The major risk determinant for this disease is the polymorphic codon 129 of the human prion protein (Hu-PrP), where either methionine (Met(129)) or valine (Val(129)) can be encoded. To date, all clinical and neuropathologically confirmed vCJD cases have been Met(129) homozygous, with the exception of 1 recently reported Met/Val heterozygous case. Here, we found that transgenic mice homozygous for Val(129) Hu-PrP show severely restricted propagation of the BSE prion strain, but this constraint can be partially overcome by adaptation of the BSE agent to the Met(129) Hu-PrP. In addition, the transmission of vCJD to transgenic mice homozygous for Val(129) Hu-PrP resulted in a prion with distinct strain features. These observations may indicate increased risk for vCJD secondary transmission in Val(129) Hu-PrP–positive humans with the emergence of new strain features. Centers for Disease Control and Prevention 2017-09 /pmc/articles/PMC5572891/ /pubmed/28820136 http://dx.doi.org/10.3201/eid2309.161948 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Fernández-Borges, Natalia Espinosa, Juan Carlos Marín-Moreno, Alba Aguilar-Calvo, Patricia Asante, Emmanuel A. Kitamoto, Tetsuyuki Mohri, Shirou Andréoletti, Olivier Torres, Juan María Protective Effect of Val(129)-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease |
title | Protective Effect of Val(129)-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease |
title_full | Protective Effect of Val(129)-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease |
title_fullStr | Protective Effect of Val(129)-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease |
title_full_unstemmed | Protective Effect of Val(129)-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease |
title_short | Protective Effect of Val(129)-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease |
title_sort | protective effect of val(129)-prp against bovine spongiform encephalopathy but not variant creutzfeldt-jakob disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572891/ https://www.ncbi.nlm.nih.gov/pubmed/28820136 http://dx.doi.org/10.3201/eid2309.161948 |
work_keys_str_mv | AT fernandezborgesnatalia protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease AT espinosajuancarlos protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease AT marinmorenoalba protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease AT aguilarcalvopatricia protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease AT asanteemmanuela protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease AT kitamototetsuyuki protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease AT mohrishirou protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease AT andreolettiolivier protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease AT torresjuanmaria protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease |